Group 1 - EXEL Industries is a French Société Anonyme with a share capital of €16,969,750 [1] - The registered office is located at 54, rue Marcel Paul, 51206 Epernay Cedex, France [1] - The company is registered under the Reims Companies Register (RCS) with the number 095 550 356 [1] Group 2 - As of June 30, 2025, the total number of shares is 6,787,900 [2] - The theoretical voting rights amount to 9,891,571 [2] - The exercisable voting rights, after deduction of shares without voting rights, are 9,887,244 [2]

Core Viewpoint - Extendicare Inc. has successfully acquired Closing the Gap Healthcare Group Inc. for $75.5 million, enhancing its home healthcare services and capabilities in rehabilitation [1][2][3] Group 1: Acquisition Details - The acquisition of Closing the Gap was completed on July 1, 2025, on a debt-free, cash-free basis, with an initial cash consideration of $75.5 million, subject to adjustments [2] - An additional earnout of $3.5 to $5.5 million is anticipated based on new business revenue generated in the twelve months following the acquisition [2] - The purchase price was funded through cash on hand and existing senior secured credit facilities [2] Group 2: Financial Strategy - Extendicare announced a $100 million increase to its Senior Secured Credit Facility, raising the total to $375 million, which includes $55 million in a delayed draw term loan and $45 million in a revolving credit facility [3] - The company plans to utilize the additional $55 million in the third quarter for strategic acquisitions and organic growth [4] Group 3: Company Overview - Extendicare is a leading provider of care and services for seniors in Canada, operating 99 long-term care homes and delivering approximately 11.2 million hours of home health care services annually [6] - The company employs around 27,500 qualified team members dedicated to providing high-quality care [6]

Core Viewpoint - Extendicare Inc. has received approval from the Toronto Stock Exchange for the renewal of its normal course issuer bid, allowing the company to repurchase up to 7,281,193 common shares, which is 10% of its public float [1][4] Group 1: NCIB Details - The NCIB will commence on July 2, 2025, and will continue until July 1, 2026, or until the bid is completed [2] - Daily purchases under the NCIB will be limited to 44,803 common shares based on the average daily trading volume of 179,213 shares over the last six months [2] - All common shares purchased under the NCIB will be cancelled [3] Group 2: Rationale and Strategy - The board of directors believes that purchasing common shares may be an attractive use of corporate funds based on market conditions and share price [4] - The company has not purchased any shares under its previous NCIB, which allowed for the purchase of up to 7,159,997 common shares [5] Group 3: Automatic Purchase Plan - Extendicare has established an automatic purchase plan with its designated broker to facilitate share purchases during regulatory black-out periods [6] Group 4: Company Overview - Extendicare is a leading provider of care and services for seniors in Canada, operating 99 long-term care homes and delivering approximately 11.2 million hours of home health care services annually [7] - The company employs around 26,500 qualified team members dedicated to providing high-quality care [7]

MARKHAM, Ontario, June 16, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. ("Extendicare" or the "Company") (TSX: EXE) announced that it has declared a cash dividend of C$0.042 per common share of the Company for the month of June 2025, which is payable on July 15, 2025 to shareholders of record at the close of business on June 30, 2025. This dividend is designated as an "eligible dividend" within the meaning of the Income Tax Act (Canada). About Extendicare Extendicare is a leading provider of care and services ...

Company Information - EXEL Industries is a French Société Anonyme with a share capital of €16,969,750 [1] - The registered office is located at 54, rue Marcel Paul, 51206 Epernay Cedex, France [1] - The company is registered under the Reims Companies Register (RCS) with the number 095 550 356 [1] Share and Voting Rights - As of May 31, 2025, the total number of shares is 6,787,900 [2] - The theoretical voting rights amount to 9,891,627 [2] - The exercisable voting rights, after deduction of shares without voting rights, are 9,886,797 [2]

Company Overview - Expand Energy Corporation is a leading U.S.-based natural gas producer formed through the merger of Chesapeake Energy Corporation and Southwestern Energy Company, completed on October 1, 2024 [11] - The merger positioned Expand Energy as the largest natural gas producer in the country, leveraging a vast asset base across the Haynesville and Appalachian shale plays [11] - The combined entity has more than 5,000 gross drilling locations and an extensive inventory expected to sustain development for over 15 years [11] Operational Efficiency - The merger enhanced operational scale and efficiency, unlocking cost synergies and providing a strong platform to capitalize on growing natural gas demand, particularly from the liquefied natural gas (LNG) sector [11] Stock Performance - Expand Energy is currently rated 3 (Hold) on the Zacks Rank, with a VGM Score of A [12] - The stock has a Momentum Style Score of B, with shares up 9% over the past four weeks [12] - Four analysts revised their earnings estimate higher in the last 60 days for fiscal 2025, with the Zacks Consensus Estimate increasing by $0.09 to $7.68 per share [12] - The company boasts an average earnings surprise of 72.9% [12] Investment Potential - With a solid Zacks Rank and top-tier Momentum and VGM Style Scores, Expand Energy should be on investors' short list [13]

Core Points - Extendicare Inc. has completed the acquisition of nine "Class C" long-term care homes and a parcel of vacant land from Revera Inc. effective June 1, 2025 [1] - The total consideration for the transaction was approximately $60.3 million, consisting of $40.2 million in cash and the assumption of $20.1 million in liabilities [2] - The acquired homes include a total of 822 long-term care beds and 574 retirement beds across various locations in Ontario and Manitoba [3] Financial Details - The purchase price was funded from cash on hand, excluding transaction costs [2] - The liabilities assumed include government funding reimbursement obligations and committed capital maintenance project obligations [2] Operational Insights - Carlingview Manor is undergoing redevelopment into a new 320-bed long-term care home, owned by a joint venture between Extendicare and Axium [4] - Extendicare operates a network of 99 long-term care homes, providing approximately 11.2 million hours of home health care services annually [5] - The company employs around 26,500 qualified team members dedicated to delivering high-quality care [5]

Core Viewpoint - Expand Energy (EXE) shares have increased by approximately 11.1% since the last earnings report, outperforming the S&P 500, but recent estimates have trended downward, indicating potential challenges ahead [1][2]. Group 1: Earnings Performance - The last earnings report for Expand Energy was about a month ago, and the stock has shown positive performance since then [1]. - The consensus estimate for the company has decreased by 9.3% over the past month, reflecting a negative shift in expectations [2]. Group 2: VGM Scores - Expand Energy currently holds a strong Growth Score of A, but has a lower Momentum Score of D, indicating mixed performance across different investment strategies [3]. - The stock has a value grade of C, placing it in the middle 20% for this investment strategy, leading to an overall aggregate VGM Score of B [3]. Group 3: Outlook - The overall trend for estimates has been downward, suggesting a potential decline in performance expectations for Expand Energy [4]. - The company holds a Zacks Rank of 3 (Hold), indicating an expectation of an in-line return in the coming months [4].

Core Points - Extendicare Inc. held its annual and special meeting of shareholders on May 27, 2025, where various matters were voted on [1] - A total of 47,282,730 common shares were represented at the meeting, accounting for 56.41% of the outstanding shares [2] Group 1: Election of Directors - Nine nominees were elected as directors to serve until the next annual meeting [3] - The voting results showed high approval rates for the nominees, with votes for ranging from 94.08% to 99.74% [4] Group 2: Appointment of Auditors - KPMG LLP was appointed as the auditors of the Company until the next annual meeting, with 87.18% of votes in favor [5][6] Group 3: Long Term Incentive Plan - The resolution to approve unallocated entitlements under Extendicare's Long Term Incentive Plan was passed with 97.04% approval [7][8] Group 4: Executive Compensation - A non-binding advisory resolution regarding the Company's approach to executive compensation was approved, receiving 94.48% of votes in favor [9][10][11] Company Overview - Extendicare is a leading provider of care and services for seniors in Canada, operating 122 long-term care homes and delivering approximately 11.2 million hours of home health care services annually [12]

Core Viewpoint - EXEL Industries reported a decline in revenue and recurring EBITDA for the first half of 2024-2025, primarily due to lower volumes in Agricultural Spraying, while maintaining a focus on debt reduction and cash flow optimization [5][13]. Financial Performance - Revenue for the first half of 2024-2025 was €443.4 million, down 10.0% from €492.7 million in the same period of 2023-2024 [5][6]. - Recurring EBITDA decreased to €20.3 million, representing 4.6% of revenue, compared to 6.2% in the previous year [7][5]. - Net income was €1.5 million, a decline from €4.7 million in the first half of 2023-2024 [7][5]. Debt and Cash Flow Management - The Group's net financial debt improved by €38 million, standing at €174.5 million compared to €212.7 million in the previous year, due to efforts in reducing working capital requirements (WCR) and inventory levels [9][5]. - Despite a negative change in WCR of €30 million, the Group's focus on cash flow generation and debt reduction remains a priority [9][13]. Segment Performance - Agricultural Spraying revenue fell by €53.4 million, or 21.5%, reflecting a significant decline in volumes [4][6]. - Other segments, such as Sugar Beet and Industrial Spraying, showed stable or slight growth, with Sugar Beet revenue remaining relatively unchanged [4][6]. Future Outlook - Order intake in Agricultural Spraying is showing limited visibility but signs of recovery in Europe, while market conditions for Sugar Beet Harvesting remain uncertain [12][15]. - The Group plans to continue aligning production capacities and cost structures with business levels in response to lower volumes [15][12]. Investment and Capex - Capital expenditures (Capex) amounted to €15.6 million, including ongoing construction of a new plant in Stains, France [10].